Proteomics and metabolomics delve into the dynamic functional layers of biological systems, offering critical insights beyond genomic information. Proteomics focuses on large-scale analysis of protein expression, structure, interactions, and post-translational modifications, shedding light on cellular behavior and disease mechanisms. Metabolomics, on the other hand, profiles the complete set of small-molecule metabolites within a biological system, providing a snapshot of physiological states and metabolic changes in real time. These disciplines are instrumental in biomarker discovery, drug development, systems biology, and personalized medicine. Advanced tools such as mass spectrometry, NMR spectroscopy, and bioinformatics platforms are essential in navigating the complexity of biological networks. Proteomics and metabolomics collectively contribute to understanding disease progression, optimizing therapeutics, and predicting treatment outcomes with unparalleled precision.
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Ancient wisdom, modern science: Biotech services transforming ayurveda
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain